Drug Shortage Report for MAR-CLOPIDOGREL
Report ID | 129298 |
Drug Identification Number | 02422255 |
Brand name | MAR-CLOPIDOGREL |
Common or Proper name | CLOPIDOGREL |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CLOPIDOGREL |
Strength(s) | 75MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 TABLET |
ATC code | B01AC |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-12-03 |
Actual start date | 2020-12-03 |
Estimated end date | 2023-04-30 |
Actual end date | 2023-06-13 |
Shortage status | Resolved |
Updated date | 2023-07-11 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2023-07-11 | French | Compare |
v12 | 2023-07-11 | English | Compare |
v11 | 2023-02-16 | French | Compare |
v10 | 2023-02-16 | English | Compare |
v9 | 2022-07-20 | French | Compare |
v8 | 2022-07-20 | English | Compare |
v7 | 2021-06-09 | French | Compare |
v6 | 2021-06-09 | English | Compare |
v5 | 2021-06-09 | French | Compare |
v4 | 2021-06-09 | English | Compare |
v3 | 2020-12-04 | English | Compare |
v2 | 2020-12-03 | French | Compare |
v1 | 2020-12-03 | English | Compare |
Showing 1 to 13 of 13